Medication info

WITUD Tablet

Prescription medicationTabletOralApproval withdrawn
Ingredient · strength
Tripotassium Bismuth Dicitrate›200mg / 1 tabletRanitidine Hydrochloride›168mg / 1 tabletSucralfate Hydrate›600mg / 1 tablet
Manufacturer / importer
Dongkwang Pharmaceutical Co., Ltd.
Appearance
Green rectangular film-coated tablet
Packaging
10 tablets/bottle, 30 tablets/bottle, 300 tablets/bottle
Approval status
Approval withdrawn

MFDS item code 201904456 · Approved 2019.06.28

This product's status changed to Approval withdrawn on 2024.03.19. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of gastrointestinal disorders (including ulcers and gastritis) and Zollinger-Ellison syndrome; prevention of Mendelson syndrome
Who takes it
Adults
Adult dose
Usually, regardless of meals, administer 1 tablet orally twice daily, in the morning and at bedtime. 1) Gastric and duodenal ulcers Administer 1 tablet twice daily or 2 tablets once daily at bedtime. In particular, a higher healing rate may be achieved in patients with duodenal ulcers by administering 2 tablets twice daily, in the morning and at bedtime. The same dosage applies to combination therapy for ulcers caused by nonsteroidal anti-inflammatory drugs or for prevention of gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drug use usually heal within 4 weeks, and ulcers usually heal within 8 weeks, although healing may occasionally take longer depending on the patient. For patients with recurrent ulcers who responded well to short-term treatment with this drug, administer 1 tablet once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 1 tablet twice daily for 8 weeks or 2 tablets once daily at bedtime. However, for patients with severe reflux esophagitis, the dose may be increased to 2 tablets 4 times daily. 3) Zollinger-Ellison syndrome Initiate treatment with 1 tablet 3 times daily as the initial dose, and increase the dose as needed. In severe cases, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions Once oral administration is possible, switch from injection to oral administration and give 1 tablet twice daily. 5) Premedication before anesthesia (prevention of Mendelson's syndrome) Administer 1 tablet 2 hours before induction of anesthesia. It is preferable to also administer 1 tablet on the night before surgery.

Ingredients

Manufacturer
Dongkwang Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of gastrointestinal disorders (including ulcers and gastritis) and Zollinger-Ellison syndrome; prevention of Mendelson syndrome

  • Gastric ulcers
  • duodenal ulcers
  • gastritis
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • Mendelson syndrome
  • postoperative ulcers
  • gastric ulcers caused by NSAIDs
  • duodenal ulcers caused by NSAIDs
View approved original text

This medication is used for gastric and duodenal ulcers, gastritis, Zollinger-Ellison syndrome, gastroesophageal reflux disease, prevention of anesthesia-related complications before surgery, postoperative ulcers, and for the treatment of gastric and duodenal ulcers caused by non-steroidal anti-inflammatory drugs (NSAIDs).

How to take

Adult dose

Usually, regardless of meals, administer 1 tablet orally twice daily, in the morning and at bedtime. 1) Gastric and duodenal ulcers Administer 1 tablet twice daily or 2 tablets once daily at bedtime. In particular, a higher healing rate may be achieved in patients with duodenal ulcers by administering 2 tablets twice daily, in the morning and at bedtime. The same dosage applies to combination therapy for ulcers caused by nonsteroidal anti-inflammatory drugs or for prevention of gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drug use usually heal within 4 weeks, and ulcers usually heal within 8 weeks, although healing may occasionally take longer depending on the patient. For patients with recurrent ulcers who responded well to short-term treatment with this drug, administer 1 tablet once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 1 tablet twice daily for 8 weeks or 2 tablets once daily at bedtime. However, for patients with severe reflux esophagitis, the dose may be increased to 2 tablets 4 times daily. 3) Zollinger-Ellison syndrome Initiate treatment with 1 tablet 3 times daily as the initial dose, and increase the dose as needed. In severe cases, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions Once oral administration is possible, switch from injection to oral administration and give 1 tablet twice daily. 5) Premedication before anesthesia (prevention of Mendelson's syndrome) Administer 1 tablet 2 hours before induction of anesthesia. It is preferable to also administer 1 tablet on the night before surgery.

Precautions

This medication should not be used in patients undergoing dialysis or with impaired kidney function. In addition, it should not be administered to patients who have had allergic reactions to this drug or its components, a history of acute porphyria, those who have undergone upper gastrointestinal surgery, pregnant women or those of childbearing potential, premature infants, neonates, and patients on potassium-restricted diets. Patients with liver dysfunction or a history of drug allergies, the elderly, those with a history of kidney problems, and patients taking non-steroidal anti-inflammatory drugs should exercise extra caution when using this medication. Particularly, as this medication can mask symptoms of gastric cancer, patients with gastric ulcers or those over middle age who have newly developed or altered dyspeptic symptoms must confirm malignancy before treatment. Patients with gastric or duodenal ulcers infected with Helicobacter pylori require additional treatment for bacterium eradication. Patients in intensive care or those with hypophosphatemia, and those experiencing difficulty swallowing should also be careful when using this medication. While taking this medication, allergic reactions, skin rashes, blood disorders, hepatic dysfunction, cardiac arrhythmias, gastrointestinal symptoms, and neurological symptoms may occasionally occur; any abnormal symptoms should be reported to healthcare professionals immediately. It is important not to use this medication for an extended period without observing therapeutic effects; if not effective, switching to another medication is advised, along with regular blood tests and assessments of liver and kidney functions. Additionally, if dizziness or drowsiness occurs, it is advisable to avoid driving or operating hazardous machinery. This medication may interact with other drugs, so if taking other medications, it is essential to inform healthcare professionals, as dosage adjustments may be needed for some medications when taken concurrently. It is safest for women who are pregnant or breastfeeding to avoid using this medication, and safety in children has not been established, so administration should be avoided if possible. Finally, in cases of overdose, emergency treatments such as vomiting or gastric lavage may be necessary, and because this medication reduces gastric acid secretion which may promote bacterial growth in the gastrointestinal tract, regular check-ups including ophthalmological examinations are recommended for long-term use.

Side effects

  • Anaphylactic shock
  • skin rash
  • hives
  • angioedema
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • granulocytopenia
  • leukopenia
Show 57 more
  • thrombocytopenia
  • elevated serum enzyme levels
  • agranulocytosis
  • pancytopenia
  • myelosuppression
  • aplastic anemia
  • acquired immune hemolytic anemia
  • eosinophilia
  • increased AST
  • increased ALT
  • increased r-GTP
  • increased ALP
  • jaundice hepatitis
  • non-jaundice hepatitis
  • tachycardia
  • bradycardia
  • atrioventricular block
  • premature ventricular contraction
  • arrhythmia
  • vasculitis
  • nausea
  • vomiting
  • constipation
  • diarrhea
  • abdominal distension
  • abdominal pain
  • loss of appetite
  • dizziness
  • drowsiness
  • confusion
  • convulsions
  • excitement
  • insomnia
  • headache
  • heaviness in the head
  • sense of illness
  • anxiety
  • mental confusion
  • depression
  • hallucinations
  • blurred vision
  • involuntary movement disorders
  • consciousness disturbances
  • hypertrophic muscle cramps
  • gynecomastia
  • excessive milk secretion
  • erectile dysfunction
  • decreased libido
  • arthralgia
  • myalgia
  • rhabdomyolysis
  • skin rash
  • erythema multiforme
  • alopecia
  • glossitis
  • skin itchiness
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. The storage temperature should be maintained at room temperature between 1 and 30 degrees Celsius. This helps preserve the effectiveness of the medication for longer.

Appearance and packaging

Appearance

Green rectangular film-coated tablet

Package unit

10 tablets/bottle, 30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.